Bunge Global SA (NYSE:BG) filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on October 29, 2026, reporting third-quarter net sales of $23,804 million and nine-month net income attributable to Bunge shareholders of $1,064 million.

Key Highlights

  • Q3 2026 net sales: $23,804 million, compared with $22,155 million in Q3 2025, according to the filing.
  • Q3 2026 gross profit: $1,332 million, up from $1,063 million in the prior-year quarter, as reported.
  • Nine-month net income attributable to Bunge shareholders: $1,064 million, versus $721 million for the nine months ended September 30, 2025.
  • Diluted earnings per share (continuing operations, nine months): $5.45, compared with $4.62 in the same period of 2025.
  • Total assets as of September 30, 2026: $49,656 million, up from $44,528 million at December 31, 2025.
  • Shares outstanding as of October 27, 2026: 192,143,784 registered shares, par value $0.01 per share.
  • Short-term debt: $6,471 million as of September 30, 2026, compared with $3,883 million at December 31, 2025.

Bunge Global Q3 2026 Financial Results: Income, Balance Sheet, and Cash Position

According to the filing, Bunge Global SA reported net sales of $23,804 million for the three months ended September 30, 2026, an increase from $22,155 million in the comparable quarter of 2025. Cost of goods sold was $22,472 million in Q3 2026, resulting in gross profit of $1,332 million. Income from continuing operations before income tax was $515 million for the quarter, and income tax expense was $168 million, leaving income from continuing operations at $347 million. Net income attributable to Bunge shareholders for Q3 2026 was $318 million, or $1.64 per diluted share.

For the nine months ended September 30, 2026, the filing reported net sales of $69,706 million and net income attributable to Bunge shareholders of $1,064 million, compared with $46,567 million in net sales and $721 million in net income attributable to Bunge shareholders for the nine months ended September 30, 2025. The nine-month diluted earnings per share from continuing operations were $5.45 in 2026 versus $4.62 in 2025. Selling, general and administrative expenses for the nine months were $1,742 million, and interest expense was $586 million.

The condensed consolidated balance sheet as of September 30, 2026 showed total assets of $49,656 million, with inventories of $16,624 million and cash and cash equivalents of $524 million, compared with $1,135 million in cash at December 31, 2025. Total Bunge shareholders' equity was $16,296 million. Short-term debt rose to $6,471 million from $3,883 million at year-end 2025, and long-term debt stood at $8,944 million. Treasury shares totaled 16,369,420 as of September 30, 2026, carried at a cost of $1,209 million.

What Was Disclosed

Bunge Global SA disclosed its unaudited condensed consolidated financial statements for the three and nine months ended September 30, 2026, covering income, comprehensive income, balance sheet, and cash flow data, as part of its quarterly Form 10-Q report.